Copyright
©The Author(s) 2023.
World J Gastroenterol. Jul 21, 2023; 29(27): 4334-4343
Published online Jul 21, 2023. doi: 10.3748/wjg.v29.i27.4334
Published online Jul 21, 2023. doi: 10.3748/wjg.v29.i27.4334
Table 2 Reasons for discontinuation of azathioprine treatment
| Reason for discontinuation | Patients, n | % of 274 total |
| Inefficacy | 44 | 16.1 |
| Relapse | 37 | 13.5 |
| Remission | 69 | 25.2 |
| Pancreatitis or isolated raised in amylase/lipase or ALT > 2×ULN | 48 | 17.5 |
| Leukopenia | 23 | 8.4 |
| Infections | 13 | 4.5 |
| Unspecified intolerance | 9 | 3.3 |
| Nausea/vomiting | 15 | 5.5 |
| Neoplasia | 3 | 1.1 |
| Asthenia | 2 | 0.7 |
| Pregnancy desire | 4 | 1.4 |
| Surgery not associated with IBD | 2 | 0.7 |
| Unspecific patient voluntary | 5 | 2.1 |
- Citation: Crepaldi M, Maniero D, Massano A, Pavanato M, Barberio B, Savarino EV, Zingone F. Azathioprine monotherapy withdrawal in inflammatory bowel diseases: A retrospective mono-centric study. World J Gastroenterol 2023; 29(27): 4334-4343
- URL: https://www.wjgnet.com/1007-9327/full/v29/i27/4334.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i27.4334